Balyasny Asset Management’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.78M Buy
205,723
+56,450
+38% +$764K ﹤0.01% 1064
2025
Q1
$2.37M Buy
149,273
+131,487
+739% +$2.09M ﹤0.01% 1111
2024
Q4
$219K Buy
+17,786
New +$219K ﹤0.01% 1723